Results 1 to 10 of about 4,542 (207)
Idiopathic pulmonary fibrosis [PDF]
Orphanet Journal of Rare Diseases, 2008 Idiopathic pulmonary fibrosis (IPF) is a non-neoplastic pulmonary disease that is characterized by the formation of scar tissue within the lungs in the absence of any known provocation.
Noble Paul W, Meltzer Eric B
doaj +3 more sources
Idiopathic Pulmonary Fibrosis (IPF): An Overview [PDF]
Journal of Clinical Medicine, 2018 Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised by chronic, progressive scarring of the lungs and the pathological hallmark of usual interstitial pneumonia. Current paradigms suggest alveolar epithelial cell damage is a key initiating factor. Globally, incidence of the disease is rising, with associated high morbidity,
Conal Hayton +2 more
exaly +3 more sources
[Idiopathic pulmonary fibrosis].
Medecine sciences : M/S, 2022 38;6 ...
Hennion, Nathan +4 more
+9 more sources
Idiopathic pulmonary fibrosis: current diagnosis and treatment [PDF]
Jornal Brasileiro de Pneumologia, 2023 Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disease without a clear recognizable cause. IPF has been at the forefront of new diagnostic algorithms and treatment developments that led to a shift in patients’ care in the past decade ...
Alexandre Franco Amaral +2 more
doaj +1 more source
Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis
Scientific Reports, 2023 Idiopathic pulmonary fibrosis (IPF) is the most common and serious type of idiopathic interstitial pneumonia, characterized by chronic, progressive, and low survival rates, while unknown disease etiology.
Zenan Wu +7 more
doaj +1 more source
IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis.
PLoS ONE, 2021 Idiopathic pulmonary fibrosis is a chronic, fibrosing interstitial pneumonia that presents with various clinical courses and progression ranging from rapid to slow.
Yu Nakanishi +11 more
doaj +1 more source
La Presse Médicale, 2023 Idiopathic pulmonary fibrosis (IPF) is a progressive devastating lung disease with substantial morbidity. It is associated with cough, dyspnea and impaired quality of life. If left untreated, IPF has a median survival of 3 years. IPF affects ∼3 million people worldwide, with increasing incidence in older patients. The current concept of pathogenesis is
Thomas Koudstaal, Marlies S. Wijsenbeek
openaire +2 more sources
Pulmonary Circulation, 2021 The implications of the recent change in the definition of pulmonary hypertension on epidemiology and outcomes are not known. We sought to determine the percentage of patients with the two most common lung diseases that would be reclassified regarding ...
Steven D. Nathan +7 more
doaj +1 more source
Frontiers in Medicine, 2022 Patients with idiopathic pulmonary fibrosis are screened for circulating autoantibodies as part of the initial interstitial lung disease workup. Management of seropositive idiopathic pulmonary fibrosis is currently considered no different than that of ...
Paraskevi Kirgou +8 more
doaj +1 more source
Medicina Clínica (English Edition), 2017 Idiopathic pulmonary fibrosis is a fibrosing interstitial pneumonia associated with the radiological and/or histological pattern of usual interstitial pneumonia. Its aetiology is unknown, but probably comprises the action of endogenous and exogenous micro-environmental factors in subjects with genetic predisposition.
Antoni, Xaubet +2 more
+9 more sources